PASSIFLORA INCARNATA FLOWERING TOP

N/A

Manufactured by Boiron

226 FDA adverse event reports analyzed

Last updated: 2026-04-15

About PASSIFLORA INCARNATA FLOWERING TOP

PASSIFLORA INCARNATA FLOWERING TOP is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Boiron. The most commonly reported adverse reactions for PASSIFLORA INCARNATA FLOWERING TOP include DRUG INTERACTION, JAUNDICE, PYREXIA, ASTHENIA, DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PASSIFLORA INCARNATA FLOWERING TOP.

Top Adverse Reactions

DRUG INTERACTION7 reports
JAUNDICE7 reports
PYREXIA7 reports
ASTHENIA6 reports
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS6 reports
HEADACHE6 reports
HEPATIC FAILURE6 reports
ABDOMINAL PAIN5 reports
ARTHRALGIA5 reports
DIARRHOEA5 reports
DIZZINESS4 reports
HYPOPROTEINAEMIA4 reports
LEUKOCYTOSIS4 reports
OEDEMA PERIPHERAL4 reports
RENAL FAILURE4 reports
SOMNOLENCE4 reports
ASCITES3 reports
BILIRUBIN CONJUGATED ABNORMAL3 reports
BLOOD CREATINE PHOSPHOKINASE INCREASED3 reports
BLOOD CREATININE ABNORMAL3 reports
CELL DEATH3 reports
CHILLS3 reports
CHOLESTASIS3 reports
CONSTIPATION3 reports
DISORIENTATION3 reports
DYSPHONIA3 reports
EXPOSURE DURING PREGNANCY3 reports
HEPATITIS C3 reports
HEPATOMEGALY3 reports
HYPOVENTILATION3 reports
INTERSTITIAL LUNG DISEASE3 reports
MYALGIA3 reports
OEDEMA3 reports
PERICARDIAL EFFUSION3 reports
PLEURAL EFFUSION3 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS3 reports
ABORTION SPONTANEOUS2 reports
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS2 reports
DRUG DEPENDENCE2 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION2 reports
EATING DISORDER2 reports
FALL2 reports
INSOMNIA2 reports
OFF LABEL USE2 reports
OVERDOSE2 reports
PAIN2 reports
PRODUCT USE IN UNAPPROVED INDICATION2 reports
PRURITUS2 reports
RENAL PAIN2 reports
SEIZURE2 reports
TOXICITY TO VARIOUS AGENTS2 reports
VOMITING2 reports
WEIGHT DECREASED2 reports
WEIGHT INCREASED2 reports
ABDOMINAL INFECTION1 reports
ACUTE HEPATIC FAILURE1 reports
ANAEMIA1 reports
ANAL HAEMORRHAGE1 reports
ANXIETY1 reports
AORTIC DISORDER1 reports
BALANCE DISORDER1 reports
BLOOD POTASSIUM DECREASED1 reports
BLOOD PRESSURE SYSTOLIC INCREASED1 reports
BLOOD SODIUM DECREASED1 reports
CHEST INJURY1 reports
CHOLELITHIASIS1 reports
CHOLURIA1 reports
COMA1 reports
CONDITION AGGRAVATED1 reports
COUGH1 reports
CRYING1 reports
CYTOLYTIC HEPATITIS1 reports
DECREASED IMMUNE RESPONSIVENESS1 reports
DISTURBANCE IN ATTENTION1 reports
DRUG INEFFECTIVE1 reports
DYSPNOEA1 reports
EAR INFECTION1 reports
EOSINOPHILIA1 reports
EPISTAXIS1 reports
FANCONI SYNDROME1 reports
FEELING ABNORMAL1 reports
FOETAL CHROMOSOME ABNORMALITY1 reports
FOETAL EXPOSURE DURING PREGNANCY1 reports
GAIT DISTURBANCE1 reports
GESTATIONAL DIABETES1 reports
HALLUCINATION1 reports
HEPATITIS1 reports
HYPERCAPNIA1 reports
HYPONATRAEMIA1 reports
HYPOXIA1 reports
ILLNESS1 reports
IMPATIENCE1 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION1 reports
INCREASED APPETITE1 reports
INFLUENZA1 reports
INTENTIONAL OVERDOSE1 reports
INTENTIONAL SELF INJURY1 reports
MECONIUM ASPIRATION SYNDROME1 reports
MOOD ALTERED1 reports
MUSCULAR WEAKNESS1 reports

Report Outcomes

Out of 46 classified reports for PASSIFLORA INCARNATA FLOWERING TOP:

Serious 97.8%Non-Serious 2.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female27 (64.3%)
Male15 (35.7%)

Reports by Age

Age 326 reports
Age 154 reports
Age 864 reports
Age 883 reports
Age 412 reports
Age 552 reports
Age 652 reports
Age 21 reports
Age 131 reports
Age 181 reports
Age 381 reports
Age 421 reports
Age 471 reports
Age 601 reports
Age 701 reports
Age 711 reports
Age 731 reports
Age 781 reports
Age 831 reports
Age 891 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with PASSIFLORA INCARNATA FLOWERING TOP?

This profile reflects 226 FDA FAERS reports that mention PASSIFLORA INCARNATA FLOWERING TOP. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for PASSIFLORA INCARNATA FLOWERING TOP?

Frequently reported terms in FAERS include DRUG INTERACTION, JAUNDICE, PYREXIA, ASTHENIA, DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures PASSIFLORA INCARNATA FLOWERING TOP?

Labeling and FAERS entries often list Boiron in connection with PASSIFLORA INCARNATA FLOWERING TOP. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.